'This will be one less arrow in the concern quiver.'
Approximately five months after Pfizer PFE, +1.00% and BioNTech BNTX, +9.35% received emergency use authorization from the Food and Drug Administration for their COVID-19 vaccine, the companies are now seeking full FDA approval for a shot that’s already been delivered 170 million times in America.
“I think there are some people who could be convinced to get it once it’s approved by the FDA,” said Liz Hamel, vice president and director of public opinion and survey research at the Kaiser Family Foundation. To be clear, vaccination rates are rising while polls suggest vaccine hesitancy is slipping. 57% of the country’s adult population has received at least one shot and nearly 42% are fully vaccinated, according to the U.S. Centers for Disease Control and Prevention.
The emergency use authorization process isn’t any less stringent than full approval, according a blog post from Dr. Malia Jones, an associate scientist in health geography working at the University of Wisconsin-Madison Applied Population Laboratory. “It is made based on sound scientific data. It’s just not as large a dataset as would be submitted for a full FDA approval,” she wrote.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer/BioNTech seek full FDA approval for their Covid-19 vaccinePfizer/BioNTech seeks full FDA approval for its Covid-19 vaccine, which is currently available through an emergency use authorization
Read more »
Pfizer-BioNTech seeks full FDA approval for COVID-19 vaccineLike other vaccines available in the U.S., Pfizer-BioNTech have been providing their vaccine under an emergency use authorization.
Read more »
Pfizer, BioNTech ask FDA for full approval of Covid-19 vaccineIf granted, the Pfizer vaccine would be the first in the U.S. to be fully approved.
Read more »
Pfizer, BioNTech to donate COVID-19 vaccines to Olympic athletesPfizer and BioNTech will be providing COVID-19 vaccines to Olympic athletes participating in the summer games in Tokyo.
Read more »
Pfizer, BioNTech to provide Covid-19 vaccine to Olympic athletesInitial doses are expected to be delivered to participating delegations at the end of May with the goal of ensuring the delegations receive second doses ahead of arrivals in Tokyo.
Read more »